Nutex Health Statistics
Total Valuation
Nutex Health has a market cap or net worth of $313.17 million. The enterprise value is $569.50 million.
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, after market close.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Nutex Health has 5.44 million shares outstanding. The number of shares has increased by 10.96% in one year.
| Current Share Class | 5.44M |
| Shares Outstanding | 5.44M |
| Shares Change (YoY) | +10.96% |
| Shares Change (QoQ) | +2.62% |
| Owned by Insiders (%) | 35.95% |
| Owned by Institutions (%) | 16.73% |
| Float | 3.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 97.63 |
| PS Ratio | 0.96 |
| Forward PS | 0.92 |
| PB Ratio | 4.97 |
| P/TBV Ratio | 10.21 |
| P/FCF Ratio | 15.47 |
| P/OCF Ratio | 14.69 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 15.73, with an EV/FCF ratio of 28.14.
| EV / Earnings | n/a |
| EV / Sales | 1.95 |
| EV / EBITDA | 15.73 |
| EV / EBIT | 20.65 |
| EV / FCF | 28.14 |
Financial Position
The company has a current ratio of 1.77, with a Debt / Equity ratio of 3.80.
| Current Ratio | 1.77 |
| Quick Ratio | 1.68 |
| Debt / Equity | 3.80 |
| Debt / EBITDA | 8.06 |
| Debt / FCF | 14.98 |
| Interest Coverage | 1.44 |
Financial Efficiency
Return on equity (ROE) is -35.10% and return on invested capital (ROIC) is 4.23%.
| Return on Equity (ROE) | -35.10% |
| Return on Assets (ROA) | 3.76% |
| Return on Invested Capital (ROIC) | 4.23% |
| Return on Capital Employed (ROCE) | 7.44% |
| Revenue Per Employee | $365,000 |
| Profits Per Employee | -$51,418 |
| Employee Count | 800 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 83.28 |
Taxes
In the past 12 months, Nutex Health has paid $2.87 million in taxes.
| Income Tax | 2.87M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +234.79% in the last 52 weeks. The beta is 2.30, so Nutex Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.30 |
| 52-Week Price Change | +234.79% |
| 50-Day Moving Average | 41.96 |
| 200-Day Moving Average | 22.83 |
| Relative Strength Index (RSI) | 58.19 |
| Average Volume (20 Days) | 49,867 |
Short Selling Information
The latest short interest is 29,054, so 0.53% of the outstanding shares have been sold short.
| Short Interest | 29,054 |
| Short Previous Month | 51,520 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 0.89% |
| Short Ratio (days to cover) | 0.79 |
Income Statement
In the last 12 months, Nutex Health had revenue of $292.00 million and -$41.13 million in losses. Loss per share was -$8.58.
| Revenue | 292.00M |
| Gross Profit | 86.22M |
| Operating Income | 27.58M |
| Pretax Income | -39.95M |
| Net Income | -41.13M |
| EBITDA | 36.20M |
| EBIT | 27.58M |
| Loss Per Share | -$8.58 |
Full Income StatementBalance Sheet
The company has $46.91 million in cash and $303.24 million in debt, giving a net cash position of -$256.33 million or -$47.15 per share.
| Cash & Cash Equivalents | 46.91M |
| Total Debt | 303.24M |
| Net Cash | -256.33M |
| Net Cash Per Share | -$47.15 |
| Equity (Book Value) | 79.78M |
| Book Value Per Share | 11.59 |
| Working Capital | 52.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $21.32 million and capital expenditures -$1.08 million, giving a free cash flow of $20.24 million.
| Operating Cash Flow | 21.32M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | 20.24M |
| FCF Per Share | $3.72 |
Full Cash Flow StatementMargins
Gross margin is 29.53%, with operating and profit margins of 9.45% and -14.09%.
| Gross Margin | 29.53% |
| Operating Margin | 9.45% |
| Pretax Margin | -10.12% |
| Profit Margin | -14.09% |
| EBITDA Margin | 12.40% |
| EBIT Margin | 9.45% |
| FCF Margin | 6.93% |
Dividends & Yields
Nutex Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.96% |
| Shareholder Yield | -10.96% |
| Earnings Yield | -13.13% |
| FCF Yield | 6.46% |
Analyst Forecast
The average price target for Nutex Health is $67.50, which is -4.51% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $67.50 |
| Price Target Difference | -4.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 3, 2024. It was a reverse split with a ratio of 0.1:1.
| Last Split Date | Jul 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1:1 |
Scores
Nutex Health has an Altman Z-Score of -0.18 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.18 |
| Piotroski F-Score | 6 |